Clinical trial
Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia
NCT04509973 is registered in ClinicalTrials.gov with Scandinavian Critical Care Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia
- Lead sponsor
- Scandinavian Critical Care Trials Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 27, 2020
- Completion date
- February 1, 2022
- Enrollment
- 1,000 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, hypoxia